Symbol not found

NASDAQ:VLON   00:00AM GMT
0.00
0.00 (0.00%)
Earnings Announcements

Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results

Published: 07/28/2022 12:21 GMT
Vallon Pharmaceuticals Inc (VLON) - Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update.
Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update.
Vallon Pharmaceuticals - Net Loss Was $1.8 Million for Quarter Ended June 30, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.